-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Mj/5QIDQKXYwXKpdpz/pyvyoL/l6whjv2ZrYjE2oAHTsVTPrE14zezdkq01UKvyN LHA6N9cyOyVj2mJssV1Mmw== 0000940686-96-000002.txt : 19960209 0000940686-96-000002.hdr.sgml : 19960209 ACCESSION NUMBER: 0000940686-96-000002 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960208 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-38995 FILM NUMBER: 96513244 BUSINESS ADDRESS: STREET 1: 33 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 5087775410 MAIL ADDRESS: STREET 1: 33 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LEDERMAN DAVID M CENTRAL INDEX KEY: 0000940686 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 33 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 SC 13G 1 OMB APPROVAL OMB Number: 3235-1045 Expires: Estimated average burden hours per response 14.90 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6 )* ABIOMED, INC. _______________ (Name of Issuer) Common Stock, $.01 Par Value _______________________________ (Title of Class of Securities) 003654-10-0 ___________________ (CUSIP Number) Check the box if a fee shall be filled out with this statement.*(A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 003654-10-0 13G Page 2 of 5 Pages __________ _______________ 1 NAME OF REPORTING PERSON S.S. OR I.R.S IDENTIFICATION NUMBER DAVID M. LEDERMAN ###-##-#### 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A) (B) NOT APPLICABLE 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES OF AMERICA 5 NUMBER OF SHARES BENEFICI ALLY OWNED BY EACH REPORTI NG PERSON WITH SOLE VOTING POWER 1,467,800 6 SHARED VOTING POWER 23,000 7 SOLE DISPOSITIVE POWER 1,467,800 8 SHARED DISPOSITIVE POWER 23,000 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,490,800 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 21.5% 12 TYPE OF REPORTING PERSON* IN
*SEE INSTRUCTIONS BEFORE FILLING OUT! Item 1(a) Name of Issuer: ABIOMED, Inc. Item 1(b) Address of Issuer's Principal Executive Offices: 33 Cherry Hill Drive, Danvers, Massachusetts 01923 Item 2(a) Name of Person Filing: David M. Lederman Item 2(b) Address of Principal Business Office or, if none, Residence: 33 Cherry Hill Drive, Danvers, Massachusetts 01923 Item 2(c) Citizenship: USA Item 2(d) Title of Class of Securities: Common Stock, $.01 par value Item 2(e) CUSIP Number: 003654-10-0 Item 3 Not Applicable Item 4 Ownership: (a) Amount Beneficially Owned: 1,490,800 shares, including (I) 1,428,000 shares of Class A Common Stock which are convertible into the same number of shares of Common Stock and (ii) 23,000 shares of Common Stock held by a charitable trust, of which Dr. Lederman is a trustee, and as to which Dr. Lederman disclaims beneficial ownership. Excludes 34,400 shares of Common Stock held by Dr. Lederman's wife as to which Dr. Lederman disclaims beneficial ownership. (b) Percent of Class: 21.5% (c) Number of Shares as to which such person has: Page 3 of 5 Pages (i) sole power to vote or to direct the vote : 1,467,800 shares (ii) shared power to vote or to direct the vote: 23,000 (iii) sole power to dispose or to direct the disposition of: 1,467,800 shares (iv) shared power to dispose or to direct the disposition of: 23,000 Item 5 Ownership of Five Percent or Less of Class: Not Applicable Item 6 Ownership of More than Five Percent on Behalf of Another Person: Not Applicable Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: Not Applicable Item 8 Identification and Classification of Members of the Group: Not Applicable Item 9 Notice of Dissolution of Group: Not Applicable Item 10 Certification: Not Applicable Page 4 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 8, 1996 _____________________________________ (Date) /s/ David M. Lederman _____________________________________ Signature David M. Lederman _____________________________________ (Name) Page 5 of 5 Pages -----END PRIVACY-ENHANCED MESSAGE-----